Navigation Links
Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process

ST. PETERSBURG, Fla., June 2 /PRNewswire-FirstCall/ -- The Advanced Wound Management Division of Smith & Nephew (LSE: SN; NYSE: SNN) announced today that its negative pressure wound therapy (NPWT) products will be available in nine of the ten designated metropolitan areas included in the first phase of the competitive bidding program administered by the Centers for Medicare and Medicaid Services (CMS) in the U.S. The program, which is scheduled to take effect in July 2008, was established, in part, to ensure that Medicare patients have access to quality homecare products and services and that these and their providers meet Medicare's new financial and quality standards.

The Smith & Nephew EZCARE(TM) system for in-hospital use and the V1STA(TM) portable system for home use are proven treatments for hard to heal wounds based on the well-established principles of negative pressure wound therapy. The benefits of this treatment have been demonstrated since the late 1800s. The Smith & Nephew systems are FDA-cleared and have demonstrated excellent clinical results at a lower pressure than commonly used in other NPWT technologies. This lower pressure is comfortable for the patient and can improve usage rates for the treatment in the homecare environment. The clinical effectiveness of the Chariker-Jeter(TM) technique on which the Smith & Nephew NPWT dressing system is based was documented and published in 1989(1). Recent clinical research, published in the June edition of International Wound Journal and that will be presented at the 2008 World Union of Wound Healing Societies meeting in Toronto, Canada, concludes that the Smith & Nephew gauze-based NPWT systems are clinically effective with statistically significant reduction in wound volume and wound area similar to those published for foam-based NPWT systems(2).

To help ensure that homecare patients have access to clinically-proven NPWT, Smith & Nephew recently announced that it has entered into a preferred provider agreement with Apria Healthcare, Inc. (NYSE: AHG), America's leading provider of integrated home healthcare products and services. Apria was awarded contracts to provide NPWT to beneficiaries in seven of the ten designated competitive bidding areas included in the first phase of the CMS competitive bidding program. With approximately 550 locations throughout the U.S., Apria serves over 2 million patients annually. The Apria/Smith & Nephew collaboration will provide a smooth transition from hospital to homecare, giving more patients access to clinically effective NPWT while reducing overall treatment costs. In addition to Apria being awarded contracts, Smith & Nephew NPWT systems will be available through existing regional providers in two further competitive bidding areas.

In addition, Smith & Nephew has been working in collaboration with Universal Hospital Services, Inc. (UHS) since October 2007, providing NPWT to the U.S. acute care and long-term care markets. The continuum of care is completed, through UHS focusing on acute care and LTACs, and Apria, along with our existing regional providers, providing NPWT to home patients upon hospital discharge.

As a global leader in wound care, Smith & Nephew is unique in that it offers a total wound management solution that includes NPWT and a comprehensive portfolio of advanced wound management products from ACTICOAT(TM) and ALLEVYN(TM) to VERSAJET(TM), along with service and education to help ensure that the right products are used at the right time on the right wounds. In addition to being FDA-cleared in the U.S., the Smith & Nephew NPWT systems are cleared for sale in Australia, Canada and South Africa as well as CE-marked for use in Europe.

For more information about Smith & Nephew NPWT products, please visit our Web site at


1. Chariker ME, Jeter KF, Tintle TE, Ottsford JE. Effective management of incisional and cutaneous fistulae with closed suction wound draining. Contemp. Surg. 1989; 34:59-63

2. Campbell PE, Smith GS, Smith JM. Retrospective clinical evaluation of gauze-based negative pressure wound therapy. Int. Wound J. 2008; 5: 280-286



Liz Hewitt +44 (0)20 7401 7646

Group Director Corporate Affairs

Smith & Nephew


Cindy Leggett-Flynn +1 (212) 333-3810

Robin Gilliland

Brunswick - New York

Jon Coles +44 (0) 20 7404 5959

Justine McIlroy

Brunswick - London

About Smith & Nephew

Smith & Nephew is a global medical technology business, specializing in Orthopedic Reconstruction, Orthopedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were $3.4 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the harmonization of sales practices, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

(TM) Trademark of Smith & Nephew. Certain marks registered U.S. Patent and Trademark Office.

Appendix - Notes to Editors

Smith & Nephew NPWT Products

Since May 2007, Smith & Nephew has been able to include negative pressure wound therapy (NPWT) within its comprehensive wound management product range. NPWT is a technology used to treat chronic wounds such as diabetic ulcers, pressure sores, as well as post-operative and hard-to-heal wounds. It aids in the healing of open wounds by the application of sub-atmospheric pressure.

Smith & Nephew has now added a range of NPWT products to its advanced wound management portfolio including:

EZCARE(TM) -- A NPWT system that is designed for simple operation to minimize training requirements and improve efficiency. It has a long battery life, safety alarms, patient lockout and a quiet operation. It also operates at lower vacuum levels enhancing patient comfort and compliance.

V1STA(TM) -- A NPWT system that is lightweight and easily portable. The device incorporates a range of safety features such as low vacuum alarms for detection of leaks and sensing technology to protect against high vacuum levels.

Both NPWT systems are designed to be used with a range of wound sealing dressing kits, and canisters now offered by Smith & Nephew. The EZCARE and V1STA systems involve simple dressing changes that take less nursing time and are easy to learn and teach.

SOURCE Smith & Nephew
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
2. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
3. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
4. GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
5. SmithAmundsen Elects New Partner, Linda F. Newman
6. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
7. IADR and GlaxoSmithKline Consumer Healthcare announce winners
8. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
9. Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair
10. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
11. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
Breaking Medicine Technology: